ElevateBio
ElevateBio Employees
17 people indexed:
-
Aaron Nudelman, Ph.D., J.D.
SVP, Head of Intellectual Property
k827z78fw.y2.x.6.4@fcyxr98.18c Sign up to see email03qw23y74.z2.s.q.f@cg5wsxf.grq Sign up to see email -
q4233nn.08n@z2qyc32.cxs Sign up to see email
-
Bhakti Bhargava, MBA
SVP, Head of Finance & Accounting
d588y704y.40c@cc6c1sj.0qp Sign up to see emailwk13726sc.9yy@03817ss.c20 Sign up to see email -
g2q@fk4nfng.zp1 Sign up to see email
-
Clare Murray, Ph.D., MBA
SVP, Corporate Development & Operations of Life Edit
jfg6f7n.ww.7.872@8kk2zfk.6fw Sign up to see emailqg7qgz9.99.3.368@3qz815z.f1w Sign up to see email -
7x8z8xy@4wwjpcj.j4k Sign up to see email
-
c6rwc.jqc@0pwn0k3.859 Sign up to see email
-
Heidi Wagner, J.D.
SVP, Global Head of Government Affairs
fm1yx83.f.s@mp339zp.fzy Sign up to see email932cp8x.0.f@3xxzm7c.6qy Sign up to see email -
3u70uuh.9.p@gf4yxq8.uku Sign up to see email
-
q2z10k90m@723uxmc.cp6 Sign up to see email
-
8u1hw3qd45@0c6xhuf.9c3 Sign up to see email
-
Michael Paglia, M.S.
Chief Technology Officer of BaseCamp
hxqn7fq.k.6@qfcxujj.wy4 Sign up to see emailk20zqnw.0.8@nuw6qn2.qq2 Sign up to see email -
uw13w14r@691678q.gzx Sign up to see email
-
Mitchell H. Finer, Ph.D.
President of Research and Development
ww.696yz.7j.w@j8zg99z.jjq Sign up to see emaily7.893ss.uy.4@c2q26c2.s22 Sign up to see email -
Tedd Elich, Ph.D.
Chief Scientific Officer of Life Edit
0fr0qm.1k.j@840fn2u.5g0 Sign up to see emailm32u5m.ym.x@m75qsy9.05w Sign up to see email -
s5475qj915@0fz7q0g.03q Sign up to see email
-
qdqz2k.k57@djj6g30.rz3 Sign up to see email
ElevateBio Company Information
ElevateBio is a company that specializes in cell and gene therapy innovation, providing end-to-end capabilities for the development and commercialization of genetic medicines. The company offers cGMP manufacturing and automation services, and engages in process development, analytical services, and quality assurance for therapies. ElevateBio operates technology platforms that include gene editing, cell therapy enabling technologies, and RNA, protein, and vector engineering. The company develops both ex vivo and in vivo cell and gene therapies and partners with industry and academic institutions to accelerate therapy development. ElevateBio raised $401 million in Series D financing to further accelerate its growth. Its BaseCamp facility, located in Waltham, Massachusetts, serves as a hub for manufacturing and process development.